Complete Response of a Patient With a Mismatch Repair Deficient Aggressive Pituitary Adenoma to Immune Checkpoint Inhibitor Therapy: A Case Report
CONCLUSION:
APA is a tumor with frequent recurrence and a short median expected length of survival. Here, we demonstrate the utility of immunotherapy in a single case report of APA, with complete resolution of recurrent APA and improved survival compared with life expectancy.
Source: Neurosurgery - Category: Neurosurgery Tags: Case Report: Tumor Source Type: research
More News: Brain | Brain Cancers | Cancer & Oncology | Chemotherapy | Endocrinology | Gastroschisis Repair | Immunotherapy | Neurology | Neurosurgery | Pathology | Pituitary Tumor | Proton Therapy | Radiation Therapy | Radiography | Temodar | Yervoy